Shanshan Lin

701 total citations
25 papers, 561 citations indexed

About

Shanshan Lin is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Shanshan Lin has authored 25 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Shanshan Lin's work include Caveolin-1 and cellular processes (5 papers), PARP inhibition in cancer therapy (5 papers) and Protein Degradation and Inhibitors (3 papers). Shanshan Lin is often cited by papers focused on Caveolin-1 and cellular processes (5 papers), PARP inhibition in cancer therapy (5 papers) and Protein Degradation and Inhibitors (3 papers). Shanshan Lin collaborates with scholars based in China, United States and Netherlands. Shanshan Lin's co-authors include Zhenghong Yuan, Ayalew Mergia, Xiaonan Zhang, Verena Christen, Markus H. Heim, François H.T. Duong, Xiang Li, Min Wu, Yang Xu and Lixian Wu and has published in prestigious journals such as Hepatology, Analytical Biochemistry and Journal of Virology.

In The Last Decade

Shanshan Lin

23 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanshan Lin China 14 238 172 128 102 88 25 561
Hongyan Liu China 13 244 1.0× 291 1.7× 165 1.3× 281 2.8× 118 1.3× 39 782
Zhen Yan China 14 296 1.2× 93 0.5× 40 0.3× 78 0.8× 96 1.1× 44 610
You‐Yu Lin Taiwan 15 430 1.8× 397 2.3× 254 2.0× 85 0.8× 45 0.5× 47 898
Ye Sang China 15 440 1.8× 80 0.5× 46 0.4× 32 0.3× 68 0.8× 27 584
Demin Yu China 17 221 0.9× 494 2.9× 409 3.2× 26 0.3× 99 1.1× 39 942
Amr S. Khaled United States 14 211 0.9× 250 1.5× 246 1.9× 350 3.4× 141 1.6× 24 1.0k
Youwen Tan China 15 326 1.4× 307 1.8× 233 1.8× 35 0.3× 31 0.4× 45 904
Duckhyang Shin South Korea 11 341 1.4× 124 0.7× 71 0.6× 39 0.4× 62 0.7× 16 464
Guoxin Liang China 10 159 0.7× 204 1.2× 129 1.0× 69 0.7× 137 1.6× 19 476

Countries citing papers authored by Shanshan Lin

Since Specialization
Citations

This map shows the geographic impact of Shanshan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanshan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanshan Lin more than expected).

Fields of papers citing papers by Shanshan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanshan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanshan Lin. The network helps show where Shanshan Lin may publish in the future.

Co-authorship network of co-authors of Shanshan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shanshan Lin. A scholar is included among the top collaborators of Shanshan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanshan Lin. Shanshan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Zhen, Binhua Dong, Tian Tian, et al.. (2025). Identifying Data-Driven Clinical Subgroups for Cervical Cancer Prevention With Machine Learning: Population-Based, External, and Diagnostic Validation Study. JMIR Public Health and Surveillance. 11. e67840–e67840. 1 indexed citations
2.
3.
Lin, Shanshan, et al.. (2023). Formation ability and drug resistance mechanism of Klebsiella pneumoniae biofilm and capsule for multidrug-resistant. Cellular and Molecular Biology. 69(10). 88–93. 4 indexed citations
4.
Lin, Shanshan, et al.. (2022). Synthesis of novel dual target inhibitors of PARP and EGFR and their antitumor activities in triple negative breast cancers. Bioorganic & Medicinal Chemistry. 61. 116739–116739. 15 indexed citations
5.
Li, Ge, Shanshan Lin, Xinhua Wu, et al.. (2022). A PARP1 PROTAC as a novel strategy against PARP inhibitor resistance via promotion of ferroptosis in p53-positive breast cancer. Biochemical Pharmacology. 206. 115329–115329. 43 indexed citations
6.
Lin, Shanshan, Lingyu Zhang, Jingwen Liu, et al.. (2022). Discovery of CN0 as a novel proteolysis-targeting chimera (PROTAC) degrader of PARP1 that can activate the cGAS/STING immunity pathway combined with daunorubicin. Bioorganic & Medicinal Chemistry. 70. 116912–116912. 15 indexed citations
7.
Hu, Yan, Jingwen Liu, Shanshan Lin, et al.. (2021). Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer. European Journal of Medicinal Chemistry. 228. 114013–114013. 26 indexed citations
8.
Gupta, Reeshu, Liangjie Yin, Astrid Grosche, et al.. (2020). An Amino Acid–Based Oral Rehydration Solution Regulates Radiation-Induced Intestinal Barrier Disruption in Mice. Journal of Nutrition. 150(5). 1100–1108. 14 indexed citations
9.
Lin, Shanshan, Lingyu Zhang, Xiao Zhang, et al.. (2020). Synthesis of novel dual target inhibitors of PARP and HSP90 and their antitumor activities. Bioorganic & Medicinal Chemistry. 28(9). 115434–115434. 26 indexed citations
10.
Lin, Shanshan, et al.. (2018). Characterization of antibody-C1q interactions by Biolayer Interferometry. Analytical Biochemistry. 549. 143–148. 10 indexed citations
11.
Lin, Shanshan, et al.. (2015). HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking. Retrovirology. 12(1). 62–62. 11 indexed citations
12.
Lin, Shanshan, et al.. (2014). Establishing Restricted Expression of Caveolin-1 in HIV Infected Cells and Inhibition of Virus Replication. The Open Microbiology Journal. 8(1). 114–121. 4 indexed citations
13.
Lin, Shanshan, et al.. (2012). Caveolin-1 reduces HIV-1 infectivity by restoration of HIV Nef mediated impairment of cholesterol efflux by apoA-I. Retrovirology. 9(1). 85–85. 13 indexed citations
14.
Wang, Xiao Mei, et al.. (2011). Caveolin 1 Inhibits HIV Replication by Transcriptional Repression Mediated through NF-κB. Journal of Virology. 85(11). 5483–5493. 23 indexed citations
15.
Li, Jianhua, et al.. (2010). Inhibition of Hepatitis B Virus Replication by MyD88 Involves Accelerated Degradation of Pregenomic RNA and Nuclear Retention of Pre-S/S RNAs. Journal of Virology. 84(13). 6387–6399. 68 indexed citations
16.
Lin, Shanshan, et al.. (2010). HIV Infection Upregulates Caveolin 1 Expression To Restrict Virus Production. Journal of Virology. 84(18). 9487–9496. 27 indexed citations
17.
Duong, François H.T., Verena Christen, Shanshan Lin, & Markus H. Heim. (2009). Hepatitis C Virus–Induced Up-Regulation of Protein Phosphatase 2A Inhibits Histone Modification and Dna Damage Repair. Hepatology. 51(3). 741–751. 55 indexed citations
18.
Lin, Shanshan, Min Wu, Xu Yang, et al.. (2007). Inhibition of hepatitis B virus replication by MyD88 is mediated by nuclear factor-kappaB activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1772(10). 1150–1157. 21 indexed citations
19.
Wu, Min, Yang Xu, Shanshan Lin, et al.. (2007). Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1. Journal of General Virology. 88(12). 3260–3269. 77 indexed citations
20.
Lewis, Daniel D., et al.. (1985). Gastric mast cell tumor in a cougar. Journal of the American Veterinary Medical Association. 187(11). 1258–1260. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongyan Liu Breakdown of academic impact, for papers by Zhen Yan Breakdown of academic impact, for papers by You‐Yu Lin Breakdown of academic impact, for papers by Ye Sang Breakdown of academic impact, for papers by Demin Yu Breakdown of academic impact, for papers by Amr S. Khaled Breakdown of academic impact, for papers by Youwen Tan Breakdown of academic impact, for papers by Duckhyang Shin Breakdown of academic impact, for papers by Guoxin Liang
Rankless by CCL
2026